# Estimating treatment effects from single-arm trials via latent-variable modeling

arXiv: https://arxiv.org/abs/2311.03002 · HTML: https://mlsanity.com/paper/2311.03002/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 36 of its 88 references that are in the map.
- First posted on arXiv 6 Nov 2023.

## Builds on (most cited first, 30 of 36)

- [PyTorch: An Imperative Style, High-Performance Deep Learning Library](https://mlsanity.com/paper/1912.01703/) (2019)
- [Unsupervised Domain Adaptation by Backpropagation](https://mlsanity.com/paper/1409.7495/) (2014)
- [Invariant Risk Minimization](https://mlsanity.com/paper/1907.02893/) (2019)
- [Fast and Accurate Deep Network Learning by Exponential Linear Units (ELUs)](https://mlsanity.com/paper/1511.07289/) (2015)
- [Estimation and Inference of Heterogeneous Treatment Effects using Random Forests](https://mlsanity.com/paper/1510.04342/) (2015)
- [Variational Autoencoders and Nonlinear ICA: A Unifying Framework](https://mlsanity.com/paper/1907.04809/) (2019)
- [Meta-learners for Estimating Heterogeneous Treatment Effects using Machine Learning](https://mlsanity.com/paper/1706.03461/) (2017)
- [Causal Effect Inference with Deep Latent-Variable Models](https://mlsanity.com/paper/1705.08821/) (2017)
- [Quasi-Oracle Estimation of Heterogeneous Treatment Effects](https://mlsanity.com/paper/1712.04912/) (2017)
- [Learning Representations for Counterfactual Inference](https://mlsanity.com/paper/1605.03661/) (2016)
- [Generalized Random Forests](https://mlsanity.com/paper/1610.01271/) (2016)
- [Adapting Neural Networks for the Estimation of Treatment Effects](https://mlsanity.com/paper/1906.02120/) (2019)
- [Nonlinear ICA Using Auxiliary Variables and Generalized Contrastive Learning](https://mlsanity.com/paper/1805.08651/) (2018)
- [The Benefit of Multitask Representation Learning](https://mlsanity.com/paper/1505.06279/) (2015)
- [On the Theory of Transfer Learning: The Importance of Task Diversity](https://mlsanity.com/paper/2006.11650/) (2020)
- [Nonparametric Estimation of Heterogeneous Treatment Effects: From Theory to Learning Algorithms](https://mlsanity.com/paper/2101.10943/) (2021)
- [The Blessings of Multiple Causes](https://mlsanity.com/paper/1805.06826/) (2018)
- [Time Series Deconfounder: Estimating Treatment Effects over Time in the Presence of Hidden Confounders](https://mlsanity.com/paper/1902.00450/) (2019)
- [On Inductive Biases for Heterogeneous Treatment Effect Estimation](https://mlsanity.com/paper/2106.03765/) (2021)
- [Removing Hidden Confounding by Experimental Grounding](https://mlsanity.com/paper/1810.11646/) (2018)
- [Treatment effect estimation with disentangled latent factors](https://mlsanity.com/paper/2001.10652/) (2020)
- [not-MIWAE: Deep Generative Modelling with Missing not at Random Data](https://mlsanity.com/paper/2006.12871/) (2020)
- [Approximate Residual Balancing: De-Biased Inference of Average Treatment Effects in High Dimensions](https://mlsanity.com/paper/1604.07125/) (2016)
- [Indeterminacy in Generative Models: Characterization and Strong Identifiability](https://mlsanity.com/paper/2206.00801/) (2022)
- [Combining Observational and Randomized Data for Estimating Heterogeneous Treatment Effects](https://mlsanity.com/paper/2202.12891/) (2022)
- [A Deep Variational Approach to Clustering Survival Data](https://mlsanity.com/paper/2106.05763/) (2021)
- [Benchmarking missing-values approaches for predictive models on health databases](https://mlsanity.com/paper/2202.10580/) (2022)
- [Adaptive Combination of Randomized and Observational Data](https://mlsanity.com/paper/2111.15012/) (2021)
- [Transfer Learning on Heterogeneous Feature Spaces for Treatment Effects Estimation](https://mlsanity.com/paper/2210.06183/) (2022)
- [Learning Multimodal VAEs through Mutual Supervision](https://mlsanity.com/paper/2106.12570/) (2021)

## Built on by (most cited first, 1 of 1)

- [Machine learning models for estimating counterfactuals in a single-arm inflammatory bowel disease study](https://mlsanity.com/paper/2604.23465/) (2026)

## Abstract (arXiv)

Randomized controlled trials (RCTs) are the accepted standard for treatment effect estimation but they can be infeasible due to ethical reasons and prohibitive costs. Single-arm trials, where all patients belong to the treatment group, can be a viable alternative but require access to an external control group. We propose an identifiable deep latent-variable model for this scenario that can also account for missing covariate observations by modeling their structured missingness patterns. Our method uses amortized variational inference to learn both group-specific and identifiable shared latent representations, which can subsequently be used for em (i) patient matching if treatment outcomes are not available for the treatment group, or for em (ii) direct treatment effect estimation assuming outcomes are available for both groups. We evaluate the model on a public benchmark as well as on a data set consisting of a published RCT study and real-world electronic health records. Compared to previous methods, our results show improved performance both for direct treatment effect estimation as well as for effect estimation via patient matching.
